- Filed
- Jul 21, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 49.98M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $20.4K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $563 |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $347.73K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $229.11K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $384.03K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $305.58K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $21.55K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.88K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $21.55K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.88K |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 42.55M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$57.48K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$278.72K |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$222.39K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $84.2K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$85.41K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$85.79K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$1.59K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.01K |
| Revenue | Q1 2025 · Mar 31, 2024 | $415 |